New Articles on causes and treatments for AKs, Melasma, Atopic Derm, Acne, Grover's and Contact Derm. But you can't always believe what you read in a journal, and even when you can it doesn't mean it's going to help your patients. So, sit back, relax and join the Derms on Drugs to separate fact from fiction.

• A systemic option for patients with tons of actinic keratoses all over their body? If it sounds too good to be true it probably is, right?
• Botox for melasma. Can you see the difference? Can the Derms on Drugs?
• New "Real World" data says Dupixent doesn't help 85% of patients. Are the authors living in the "Real World"?
• Hormonal IUDs cause acne - Fact, fiction or the jury is still out?
• Grover's Disease (aka transient acantholytic dermatosis) isn't always so transient. Do we finally have a breakthrough?
• Positive Patch Tests in Kids - do they actually get better or is it just sending us down a rabbit hole?

Derms on Drugs is brought to you by Scholars in Medicine.

Resource links for this episode available at Scholars in Medicine.

1. Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention
2. Intradermal Botulinum Toxin A for Melasma: A Randomized Split-Face Study Trial and In Vitro Study of Its Antimelanogenic Effect⁠
3. Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry
4. Frequency of androgenic cutaneous adverse events associated with levonorgestrel intrauterine devices: An analysis of the Food and Drug Administration Adverse Event Reporting System database
5. Efficacy of Dupilumab for Treatment-Resistant Grover's Disease: A Retrospective Study⁠
6. Association of Somatic ATP2A2 Damaging Variants With Grover Disease ⁠
7. Discrepancies in patch testing timing and outcomes: A retrospective analysis of the Pediatric Allergic Contact Dermatitis Registry